Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

23.46
Delayed Data
As of Dec 14
 +0.32 / +1.38%
Today’s Change
15.31
Today|||52-Week Range
29.20
+32.32%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close23.14
Today’s open23.18
Day’s range22.95 - 23.60
Volume10,429
Average volume (3 months)30,747
Market cap$205.9M
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)+47.08%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.93
Price/Book3.94

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...-0.14-2.55%
SBBPStrongbridge Biophar...-0.20-3.15%
NEOSNeos Therapeutics In...-0.35-3.43%
CMRXChimerix Inc-0.04-0.90%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$11.4M
Annual profit (last year)-$16.4M
Net profit margin-143.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
Ronald Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts